# Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a

> **NCT01414231** · PHASE3 · UNKNOWN · sponsor: **University of Leipzig** · enrollment: 850 (estimated)

## Conditions studied

- Acute Myeloid Leukaemia

## Interventions

- **DRUG:** Cytarabine

## Key facts

- **NCT ID:** NCT01414231
- **Lead sponsor:** University of Leipzig
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2002-04
- **Primary completion:** 2013-12
- **Final completion:** 2014-07
- **Target enrollment:** 850 (ESTIMATED)
- **Last updated:** 2011-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01414231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01414231, "Comparison of the OSHO Protocol to a Standard Arm Protocol of the German AML Intergroup in Patients With AML<60a". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01414231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*